Neuro-oncology Clinical Trials in Scarborough, ME
As of June 2026, 1 paid clinical trial is recruiting for Neuro-oncology in Scarborough, Maine. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for Neuro-oncology
·Clear filters·↓ Download CSVAbout research studies in Scarborough
Scarborough has approximately 96 recruiting research studies across a wide range of therapeutic areas. Maine hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Scarborough
Researchers run research studies in Scarborough, ME at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center- Scarborough | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma | 42 |
| Maine Children's Cancer Program | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 24 |
| New England Cancer Specialists | Breast Cancer, HER2-positive Breast Cancer, Chronic Lymphocytic Leukemia | 7 |
| Maine Medical Center | Complex Congenital Heart Disease, Congenital Heart Disease in Children, Endometrial Cancer | 4 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Local Institution - 0127 | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | 1 |
| MMP Neurology | Focal Epilepsy, Tonic-Clonic Seizures | 1 |
| Maine Center For Cancer Medicine | Ovarian Cancer | 1 |
| Maine Hemophilia and Thrombosis Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| Maine Medical Center - Scarborough Campus | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 1 |
| Maine Medical Center - Scarborough Campus ( Site 6042) | Endometrial Cancer | 1 |
| Maine Medical Center Bramhall | Heart Failure, Obesity | 1 |
| Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc ( Site 0008) | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 1 |
| Maine Medical Center- Scarborough Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Partner's Women's Health | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Maine Medical Partners MaineHealth Cardiology | Atrial Fibrillation | 1 |
| Maine Medical Partners-Woman's Health-Division of Gynecologic Oncology | Cervical Cancer | 1 |
| MaineHealth | Type B Aortic Dissection | 1 |
| MaineHealth Cancer Care - Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cardiology | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| MaineHealth Pediatric Neurology | Headache, Migraine | 1 |
| MaineMed Vascular Surgery | Abdominal Aortic Aneurysm | 1 |
| Massive Bio SYNERGY-AI site | BRCA Gene Rearrangement, Bladder Cancer, Breast Cancer | 1 |
| New England Cancer Specialist | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
Active & Upcoming Studies in Scarborough (2026)
Recruiting trials in Scarborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (70 active studies)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
- A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion · Phase 2, Phase 3 · Bristol-Myers Squibb
Neurology & pain (3 active studies)
- Adolescent Lifestyle Medicine Headache Study · MaineHealth
- An Open-label Study of XEN1101 in Epilepsy · Phase 3 · Xenon Pharmaceuticals Inc.
Cardiovascular (3 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
Vaccines (1 active study)
Diabetes & metabolic (1 active study)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Pediatric (1 active study)
- Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior · Phase 2, Phase 3 · University of Utah
Common conditions studied in Scarborough
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Endometrial Cancer (4 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Recurrent Endometrial Carcinoma (4 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Scarborough
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- AstraZeneca
- Wake Forest University Health Sciences
Local regulations and guidelines
Clinical trials in Maine are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maine research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Scarborough. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Scarborough
Hipa.ai aggregates every recruiting study in Scarborough from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Scarborough?
There are approximately 96 recruiting clinical trials in Scarborough, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scarborough pay participants?
Most recruiting trials in Scarborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scarborough?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scarborough?
The most common conditions under active study in Scarborough include Acute Myeloid Leukemia (8), Breast Cancer (7), Malignant Solid Neoplasm (5), Endometrial Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scarborough?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scarborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scarborough?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scarborough?
Recruiting research sites in Scarborough include MaineHealth Maine Medical Center- Scarborough, Maine Children's Cancer Program, New England Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scarborough right now?
The largest active categories in Scarborough are Cancer & tumors (70), Neurology & pain (3), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.